Rhizome AI is a generative AI–powered intelligence platform built for the biotech and life sciences industry. It enables teams to know what the FDA or EMA thinks in seconds, not days by instantly finding, interpreting, and verifying information from regulatory, clinical, and market datasets. The platform connects to all major health authorities and clinical data sources, including FDA and EMA pre-approval therapeutics databases, CTIS, and ClinicalTrials.gov, among others. Data is refreshed at the same cadence as the regulators, ensuring users always access the most up-to-date information. Each insight generated by Rhizome AI links directly to its verified source whether a PDF, HTML page, or text file providing full transparency and easy traceability. By combining generative AI with real-time regulatory intelligence, Rhizome AI empowers biotech innovators to accelerate research, streamline compliance, and make faster, evidence-backed decisions across the entire product lifecycle.